Revolutionising diagnosis and prognosis of neurological conditions
At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored. We use the power of mathematical modelling to develop novel biomarkers that create faster paths to diagnosis and effective treatment.
BioEP - a novel digital biomarker of epilepsy
BioEP is a tool that provides objective decision support to healthcare professionals to help inform the likelihood of seizures, enabling faster and more accurate diagnosis and prognosis of epilepsy.
- Supports diagnosis from first EEG
- Informs optimal care pathway
- Indicates response to treatment
About us
Neuronostics was spun out of the University of Exeter in 2018. Our team are dedicated to developing novel biomarkers to help improve the lives of people living with neurological conditions. We are a diverse group with expertise in clinical, scientific, technology, operations and innovation fields. Supported by Innovate UK, NIHR and private equity, we won the Medilink UK National Start Up of the Year Award in 2020 and are currently focussed on trialling our technology in clinic.
Updates from Neuronostics
Here you can find our latest news, blogs, and press releases. For more regular updates about Neuronostics, please sign up to our newsletter below.
